RETA logo

Reata Pharmaceuticals (RETA) Long Term Liabilities

Annual Total Long Term Liabilities

$521.23 M
+$26.19 M+5.29%

December 31, 2022


Summary


Performance

RETA Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRETAbalance sheetmetrics:

Quarterly Long Term Liabilities

$290.20 M
-$239.45 M-45.21%

June 30, 2023


Summary


Performance

RETA Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRETAbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RETA Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.3%-43.8%
3 y3 years+123.2%-22.3%
5 y5 years+122.1%+1.2%

RETA Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-5.0%-45.2%at low
5 y5-yearat high-55.2%-45.2%-19.5%
alltimeall timeat high-55.2%-45.2%-21.4%

Reata Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Jun 2023
-
$290.20 M(-45.2%)
Mar 2023
-
$529.66 M(+1.6%)
Dec 2022
$521.23 M(+5.3%)
$521.23 M(-1.4%)
Sep 2022
-
$528.42 M(+2.3%)
Jun 2022
-
$516.59 M(+1.6%)
Mar 2022
-
$508.46 M(+2.7%)
Dec 2021
$495.03 M(+54.2%)
$495.03 M(+39.6%)
Sep 2021
-
$354.58 M(+3.5%)
Jun 2021
-
$342.68 M(+3.4%)
Mar 2021
-
$331.39 M(+3.2%)
Dec 2020
$320.96 M(+37.4%)
$320.96 M(-15.6%)
Sep 2020
-
$380.39 M(+1.8%)
Jun 2020
-
$373.59 M(+59.2%)
Mar 2020
-
$234.71 M(+0.5%)
Dec 2019
$233.55 M
$233.55 M(-7.3%)
Sep 2019
-
$251.98 M(-5.4%)
Jun 2019
-
$266.25 M(-3.1%)
DateAnnualQuarterly
Mar 2019
-
$274.69 M(+0.2%)
Dec 2018
$274.13 M(+16.8%)
$274.13 M(-2.7%)
Sep 2018
-
$281.70 M(-1.8%)
Jun 2018
-
$286.86 M(+25.7%)
Mar 2018
-
$228.15 M(-2.8%)
Dec 2017
$234.69 M(-4.0%)
$234.69 M(-3.5%)
Sep 2017
-
$243.20 M(-2.8%)
Jun 2017
-
$250.28 M(-2.7%)
Mar 2017
-
$257.29 M(+5.2%)
Dec 2016
$244.51 M(-16.1%)
$244.51 M(-3.8%)
Sep 2016
-
$254.04 M(-4.7%)
Jun 2016
-
$266.56 M(-4.4%)
Mar 2016
-
$278.95 M(-4.2%)
Dec 2015
$291.29 M(-14.8%)
$291.29 M(-4.2%)
Sep 2015
-
$303.90 M(-11.1%)
Dec 2014
$341.75 M(-12.7%)
$341.75 M
Dec 2013
$391.47 M
-

FAQ

  • What is Reata Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Reata Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Reata Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of RETA is $521.23 M

What is the all time high annual total long term liabilities for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high annual total long term liabilities is $521.23 M

What is Reata Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, RETA annual total long term liabilities has changed by +$26.19 M (+5.29%)

What is Reata Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of RETA is $290.20 M

What is the all time high quarterly long term liabilities for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high quarterly total long term liabilities is $529.66 M

What is Reata Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, RETA quarterly total long term liabilities has changed by -$226.38 M (-43.82%)